skip to main content
Overview
Toggle Button Open

December 6, 2022

PLI New York

Join Stroock Partner David K. Barr as he speaks on patent issues confronting cell and gene therapy products at PLI's Developments in Pharmaceutical and Biotech Patent Law 2022 on December 6th at 1:45 P.M. EST. 

During this session he will:

  • Summarize an Overview of Cell and Gene Therapy Products
    • Development of Cell and Gene Therapy Products
    • Approved and Pipeline Cell and Gene Therapy Products
  • Analyze BPCIA Provisions and Their Impact on Cell and Gene Therapy Products as Biologic Drugs
    • Regulatory exclusivities
    • Biosimilar Pathway
    • Biosimilar Patent Litigation
  • Understand the Patent Landscape For Cell and Gene Therapy Products
    • Patents typically associated with Cell and Gene Therapy Products
    • Cell and Gene Therapy historic patent filings
  • Discuss Current Patent Issues and Disputes Relating to Cell and Gene Therapy Products
    • Section 101 and 112 Issues Impacting Cell and Gene Therapy Products
    • Juno v. Kite relating to CAR-T Cell Therapy
    • Amgen v. Sanofi and impact on functional genus claims
    • Pending cell and gene therapy district court cases

Click here to learn more and to register.

December 6, 2022

PLI New York

Join Stroock Partner David K. Barr as he speaks on patent issues confronting cell and gene therapy products at PLI's Developments in Pharmaceutical and Biotech Patent Law 2022 on December 6th at 1:45 P.M. EST. 

During this session he will:

  • Summarize an Overview of Cell and Gene Therapy Products
    • Development of Cell and Gene Therapy Products
    • Approved and Pipeline Cell and Gene Therapy Products
  • Analyze BPCIA Provisions and Their Impact on Cell and Gene Therapy Products as Biologic Drugs
    • Regulatory exclusivities
    • Biosimilar Pathway
    • Biosimilar Patent Litigation
  • Understand the Patent Landscape For Cell and Gene Therapy Products
    • Patents typically associated with Cell and Gene Therapy Products
    • Cell and Gene Therapy historic patent filings
  • Discuss Current Patent Issues and Disputes Relating to Cell and Gene Therapy Products
    • Section 101 and 112 Issues Impacting Cell and Gene Therapy Products
    • Juno v. Kite relating to CAR-T Cell Therapy
    • Amgen v. Sanofi and impact on functional genus claims
    • Pending cell and gene therapy district court cases

Click here to learn more and to register.

Professionals